PHARMACEUTICAL CONTRACT MANUFACTURING
2nd - 3rd December 2026, London, United Kingdom
Optimizing Pharmaceutical Outsourcing Through Strategic CMOs, Innovation Scaling, Supply Chain Resilience, and Advanced Manufacturing Technologies Adoption
This strategic conference provides a comprehensive platform for pharmaceutical leaders, development specialists, manufacturing experts, and external partnership stakeholders to gain practical insights into building agile, resilient, and high-performing pharmaceutical development and manufacturing ecosystems. The discussions are designed to move beyond traditional outsourcing approaches and focus on how organisations can create strategic partnerships, improve execution capability, and accelerate the journey from innovation to commercial success.
A key learning outcome from attending this conference is the ability to understand how successful pharmaceutical development increasingly depends on strong collaboration models between sponsors, CDMOs, CMOs, and technology partners. Participants will gain valuable perspectives on how to select the right strategic partners, establish effective governance structures, manage complex global programmes, and create partnership frameworks that reduce risk while improving speed, quality, and operational reliability.
The conference will provide practical understanding of how integrated development approaches can improve decision-making across the product lifecycle. Attendees will learn how early alignment between technical, operational, quality, regulatory, and supply chain teams can prevent delays, improve technology transfer outcomes, and strengthen commercial readiness. The discussions will highlight the importance of knowledge sharing, transparent communication, and structured collaboration in overcoming challenges associated with complex pharmaceutical programmes.
Participants will also gain insights into transforming supply chains from transactional networks into strategic value-creating partnerships. Learning will focus on improving supply chain visibility, strengthening resilience, enhancing forecasting accuracy, and developing collaborative planning approaches that support reliable global product availability. The sessions will help attendees understand how joint accountability, shared objectives, and performance-driven partnerships can improve manufacturing efficiency and long-term business outcomes.
Another important benefit of joining the conference is gaining exposure to best practices for managing technology transfer and external manufacturing complexity. Attendees will learn approaches for improving transfer readiness, managing process variability, aligning technical expectations, and creating governance models that enable faster issue resolution. These insights will support organisations in reducing operational risks, improving manufacturing consistency, and achieving smoother transitions between development and commercial production.
The conference also offers strategic learning on evaluating and managing CDMO/CMO relationships. Participants will gain frameworks for assessing partner capabilities, regulatory maturity, scalability, cultural alignment, and long-term strategic fit. These insights will help organisations make more informed partnership decisions and build sustainable external manufacturing networks.
Through interactive discussions and peer networking, attendees will benefit from real-world experiences, industry perspectives, and practical approaches to solving common pharmaceutical development and manufacturing challenges. The conference enables participants to benchmark their current strategies, identify improvement opportunities, and develop stronger approaches for innovation, collaboration, capacity planning, and operational excellence.
By attending, professionals will gain actionable knowledge to improve partnership strategies, accelerate product development timelines, strengthen supply chain resilience, and enhance competitiveness in an increasingly complex pharmaceutical landscape.